Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 314

1.

Gene expression comparison between primary triple-negative breast cancer and paired axillary and sentinel lymph node metastasis.

Srour MK, Gao B, Dadmanesh F, Carlson K, Qu Y, Deng N, Cui X, Giuliano AE.

Breast J. 2019 Nov 11. doi: 10.1111/tbj.13684. [Epub ahead of print]

PMID:
31713298
2.

2019 SSO Presidential Address: Serendipity and Strategy on the Path of Progress.

Giuliano AE.

Ann Surg Oncol. 2019 Oct 11. doi: 10.1245/s10434-019-07872-0. [Epub ahead of print] No abstract available.

PMID:
31605323
3.

Flat epithelial atypia on core needle biopsy does not always mandate excisional biopsy.

Srour MK, Donovan C, Chung A, Harit A, Dadmanesh F, Giuliano AE, Amersi F.

Breast J. 2019 Sep 28. doi: 10.1111/tbj.13507. [Epub ahead of print]

PMID:
31562689
4.

Comparison of wire localization, radioactive seed, and Savi scout® radar for management of surgical breast disease.

Srour MK, Kim S, Amersi F, Giuliano AE, Chung A.

Breast J. 2019 Aug 25. doi: 10.1111/tbj.13499. [Epub ahead of print]

PMID:
31448530
5.

Impact of Resident and Fellow Participation on Surgical Outcomes in Breast Conserving Surgery for Invasive Breast Cancer.

Srour MK, Manguso N, Mirocha J, Chung A, Giuliano AE, Amersi F.

J Surg Educ. 2019 Aug 1. pii: S1931-7204(19)30382-4. doi: 10.1016/j.jsurg.2019.07.014. [Epub ahead of print]

PMID:
31377203
6.

Overuse of Preoperative Staging of Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer.

Srour MK, Lee M, Walcott-Sapp S, Luu M, Chung A, Giuliano AE, Amersi F.

Ann Surg Oncol. 2019 Oct;26(10):3289-3294. doi: 10.1245/s10434-019-07543-0. Epub 2019 Jul 24.

PMID:
31342365
7.

Patterns in the Use of Axillary Operations for Patients with Node-Positive Breast Cancer After Neoadjuvant Chemotherapy: A National Cancer Database (NCDB) Analysis.

Srour MK, Tseng J, Luu M, Alban RF, Giuliano AE, Chung A.

Ann Surg Oncol. 2019 Oct;26(10):3305-3311. doi: 10.1245/s10434-019-07540-3. Epub 2019 Jul 24.

PMID:
31342364
8.

Outcomes in patients with small node-negative invasive breast cancer.

Bao J, Donovan C, Amersi F, Zhang X, Giuliano AE, Chung A.

Breast J. 2019 Jul;25(4):638-643. doi: 10.1111/tbj.13288. Epub 2019 May 12.

PMID:
31079425
9.

Lymphovascular Invasion and the Decision for Postmastectomy Radiation Therapy: A Cautionary Case Report.

Jensen JA, Bakkar R, Burnison M, Giuliano AE.

Plast Reconstr Surg Glob Open. 2019 Feb 8;7(2):e2115. doi: 10.1097/GOX.0000000000002115. eCollection 2019 Feb.

10.

New and important changes in breast cancer TNM: incorporation of biologic factors into staging.

Edge SB, Hortobagyi GN, Giuliano AE.

Expert Rev Anticancer Ther. 2019 Apr;19(4):309-318. doi: 10.1080/14737140.2019.1582335. Epub 2019 Feb 26.

PMID:
30759347
11.

Biopsy of abnormal intramammary and axillary lymph nodes in patients without breast cancer.

Hunter-Squires J, Giuliano AE.

Breast J. 2018 Nov;24(6):867-868. doi: 10.1111/tbj.13118. No abstract available.

PMID:
30444056
12.

Adjacent skin rotation flap for large defect in primary breast tumor.

Jin L, Wu X, Zha L, Feng Y, Xu J, Zheng H, Shao J, Zhao M, Cui X, Giuliano AE, Gong Y.

J Surg Oncol. 2018 Dec;118(7):1199-1204. doi: 10.1002/jso.25240. Epub 2018 Oct 7.

PMID:
30293235
13.

circRNA meets gene amplification.

Manguso N, Giuliano AE, Tanaka H.

Noncoding RNA Investig. 2018;2. pii: 38. doi: 10.21037/ncri.2018.06.04. Epub 2018 Jun 28. No abstract available.

14.

Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer.

Giuliano AE, Edge SB, Hortobagyi GN.

Ann Surg Oncol. 2018 Jul;25(7):1783-1785. doi: 10.1245/s10434-018-6486-6. Epub 2018 Apr 18. No abstract available.

PMID:
29671136
15.

Characterization of primary human mammary epithelial cells isolated and propagated by conditional reprogrammed cell culture.

Jin L, Qu Y, Gomez LJ, Chung S, Han B, Gao B, Yue Y, Gong Y, Liu X, Amersi F, Dang C, Giuliano AE, Cui X.

Oncotarget. 2017 Dec 22;9(14):11503-11514. doi: 10.18632/oncotarget.23817. eCollection 2018 Feb 20.

16.

Axillary vs Sentinel Lymph Node Dissection in Women With Invasive Breast Cancer-Reply.

Ballman KV, McCall LM, Giuliano AE.

JAMA. 2018 Jan 16;319(3):306-307. doi: 10.1001/jama.2017.18318. No abstract available.

PMID:
29340672
17.

FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer.

Han B, Zhou B, Qu Y, Gao B, Xu Y, Chung S, Tanaka H, Yang W, Giuliano AE, Cui X.

Oncogene. 2018 Mar;37(10):1399-1408. doi: 10.1038/s41388-017-0021-2. Epub 2017 Dec 18.

18.

Impediment of Replication Forks by Long Non-coding RNA Provokes Chromosomal Rearrangements by Error-Prone Restart.

Watanabe T, Marotta M, Suzuki R, Diede SJ, Tapscott SJ, Niida A, Chen X, Mouakkad L, Kondratova A, Giuliano AE, Orsulic S, Tanaka H.

Cell Rep. 2017 Nov 21;21(8):2223-2235. doi: 10.1016/j.celrep.2017.10.103.

19.

Inhibition of lobuloalveolar development by FOXC1 overexpression in the mouse mammary gland.

Gao B, Qu Y, Han B, Nagaoka Y, Katsumata M, Deng N, Bose S, Jin L, Giuliano AE, Cui X.

Sci Rep. 2017 Oct 25;7(1):14017. doi: 10.1038/s41598-017-14342-8.

20.

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.

Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Morrow M.

JAMA. 2017 Sep 12;318(10):918-926. doi: 10.1001/jama.2017.11470.

21.

Evolution of the Staging System in Breast Cancer.

Donovan CA, Giuliano AE.

Ann Surg Oncol. 2017 Nov;24(12):3469-3470. doi: 10.1245/s10434-017-6035-8. Epub 2017 Sep 8. No abstract available.

PMID:
28887762
22.

Is Axillary Lymph Node Dissection Necessary After a Positive Sentinel Lymph Node Biopsy?

Ozcan LC, Giuliano AE.

Adv Surg. 2017 Sep;51(1):165-178. doi: 10.1016/j.yasu.2017.03.013. Epub 2017 May 13. Review. No abstract available.

PMID:
28797338
23.

Global Forum of Cancer Surgeons: Declaration of Intent.

Are C, Coit DG, McMasters KM, Giuliano AE, Anderson BO, Balch CM, Pathak KA, Audisio RA, Rubio IT, Gonzalez-Moreno S, Mori M, Eguchi H, Savant D, Prasad BKCM, Cheema MA, Chaudhry ZA, Yang HK, Park DJ, Coimbra FJF, Quadros C, Said HM, Bargallo-Rocha JE.

Ann Surg Oncol. 2017 Sep;24(9):2429-2431. doi: 10.1245/s10434-017-5951-y. Epub 2017 Jul 5. No abstract available.

PMID:
28676922
24.

Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer.

Chung S, Jin Y, Han B, Qu Y, Gao B, Giuliano AE, Cui X.

Cell Commun Signal. 2017 Jun 19;15(1):22. doi: 10.1186/s12964-017-0180-3.

25.

Bilateral Mastectomy as Overtreatment for Breast Cancer in Women Age Forty Years and Younger with Unilateral Operable Invasive Breast Cancer.

Donovan CA, Bao J, Gangi A, Amersi F, Zhang X, Giuliano AE, Chung AP.

Ann Surg Oncol. 2017 Aug;24(8):2168-2173. doi: 10.1245/s10434-017-5856-9. Epub 2017 Apr 17.

PMID:
28417238
26.

Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Giuliano AE, Connolly JL, Edge SB, Mittendorf EA, Rugo HS, Solin LJ, Weaver DL, Winchester DJ, Hortobagyi GN.

CA Cancer J Clin. 2017 Jul 8;67(4):290-303. doi: 10.3322/caac.21393. Epub 2017 Mar 14. Erratum in: CA Cancer J Clin. 2017 Jul 8;67(4):345.

27.

FOXC1: an emerging marker and therapeutic target for cancer.

Han B, Bhowmick N, Qu Y, Chung S, Giuliano AE, Cui X.

Oncogene. 2017 Jul 13;36(28):3957-3963. doi: 10.1038/onc.2017.48. Epub 2017 Mar 13. Review.

28.

Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors.

Marotta M, Onodera T, Johnson J, Budd GT, Watanabe T, Cui X, Giuliano AE, Niida A, Tanaka H.

Sci Rep. 2017 Feb 17;7:41921. doi: 10.1038/srep41921.

29.

Differentiation of Human Induced Pluripotent Stem Cells to Mammary-like Organoids.

Qu Y, Han B, Gao B, Bose S, Gong Y, Wawrowsky K, Giuliano AE, Sareen D, Cui X.

Stem Cell Reports. 2017 Feb 14;8(2):205-215. doi: 10.1016/j.stemcr.2016.12.023. Epub 2017 Jan 26.

30.

Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: 2016 American Society of Clinical Oncology Clinical Practice Guideline Update Summary.

Lyman GH, Somerfield MR, Giuliano AE.

J Oncol Pract. 2017 Mar;13(3):196-198. doi: 10.1200/JOP.2016.019992. Epub 2017 Jan 24. No abstract available.

PMID:
28118104
31.

Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE.

J Clin Oncol. 2017 Feb 10;35(5):561-564. doi: 10.1200/JCO.2016.71.0947. Epub 2016 Dec 12.

PMID:
27937089
32.

Guidelines for Guidelines: An Assessment of the American Society of Breast Surgeons Contralateral Prophylactic Mastectomy Consensus Statement.

Tuttle TM, Barrio AV, Klimberg VS, Giuliano AE, Chavez-MacGregor M, Buum HA, McMasters KM.

Ann Surg Oncol. 2017 Jan;24(1):1-2. doi: 10.1245/s10434-016-5648-7. Epub 2016 Oct 25. No abstract available.

33.

Recurrent primary hyperparathyroidism due to Type 1 parathyromatosis.

Jain M, Krasne DL, Singer FR, Giuliano AE.

Endocrine. 2017 Feb;55(2):643-650. doi: 10.1007/s12020-016-1139-7. Epub 2016 Oct 14.

PMID:
27743301
34.

FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort.

Johnson J, Choi M, Dadmanesh F, Han B, Qu Y, Yu-Rice Y, Zhang X, Bagaria S, Taylor C, Giuliano AE, Amersi F, Cui X.

Oncotarget. 2016 Nov 15;7(46):75729-75738. doi: 10.18632/oncotarget.12370.

35.

Transcriptome and proteome characterization of surface ectoderm cells differentiated from human iPSCs.

Qu Y, Zhou B, Yang W, Han B, Yu-Rice Y, Gao B, Johnson J, Svendsen CN, Freeman MR, Giuliano AE, Sareen D, Cui X.

Sci Rep. 2016 Aug 23;6:32007. doi: 10.1038/srep32007.

36.

Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.

Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Morrow M, Hunt KK.

Ann Surg. 2016 Sep;264(3):413-20. doi: 10.1097/SLA.0000000000001863.

37.

Troubleshooting Sentinel Lymph Node Biopsy in Breast Cancer Surgery.

James TA, Coffman AR, Chagpar AB, Boughey JC, Klimberg VS, Morrow M, Giuliano AE, Harlow SP.

Ann Surg Oncol. 2016 Oct;23(11):3459-3466. doi: 10.1245/s10434-016-5432-8. Epub 2016 Jul 21.

38.

Oncological and Surgical Outcomes After Nipple-Sparing Mastectomy: Do Incisions Matter?

Donovan CA, Harit AP, Chung A, Bao J, Giuliano AE, Amersi F.

Ann Surg Oncol. 2016 Oct;23(10):3226-31. doi: 10.1245/s10434-016-5323-z. Epub 2016 Jun 28.

PMID:
27352202
39.

The staging value of sentinel lymph node biopsy for breast cancer: translating pathologic findings to clinical practice.

Bao J, Donovan C, Chung A, Giuliano AE.

Chin Clin Oncol. 2016 Jun;5(3):36. doi: 10.21037/cco.2016.03.17. Epub 2016 Apr 27. Review.

40.

Sentinel Lymph Node Biopsy: From B04 to Tumor Genomics.

Bao J, Giuliano AE.

Ann Surg Oncol. 2016 Aug;23(8):2380-2. doi: 10.1245/s10434-016-5220-5. Epub 2016 Apr 13. No abstract available.

PMID:
27075322
41.

FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance.

Yu-Rice Y, Jin Y, Han B, Qu Y, Johnson J, Watanabe T, Cheng L, Deng N, Tanaka H, Gao B, Liu Z, Sun Z, Bose S, Giuliano AE, Cui X.

Oncogene. 2016 Oct 13;35(41):5400-5411. doi: 10.1038/onc.2016.78. Epub 2016 Apr 4.

42.

FOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast Cancer.

Han B, Qu Y, Jin Y, Yu Y, Deng N, Wawrowsky K, Zhang X, Li N, Bose S, Wang Q, Sakkiah S, Abrol R, Jensen TW, Berman BP, Tanaka H, Johnson J, Gao B, Hao J, Liu Z, Buttyan R, Ray PS, Hung MC, Giuliano AE, Cui X.

Cell Rep. 2015 Nov 3;13(5):1046-58. doi: 10.1016/j.celrep.2015.09.063.

43.

Neoadjuvant Chemotherapy and Surgical Management of the Axilla in Breast Cancer: A Review of Current Data.

Manguso N, Gangi A, Giuliano AE.

Oncology (Williston Park). 2015 Oct;29(10):733-8. Review.

44.

Elevated C1orf63 expression is correlated with CDK10 and predicts better outcome for advanced breast cancers: a retrospective study.

Hong CQ, Zhang F, You YJ, Qiu WL, Giuliano AE, Cui XJ, Zhang GJ, Cui YK.

BMC Cancer. 2015 Jul 25;15:548. doi: 10.1186/s12885-015-1569-2.

45.

Evaluation of MCF10A as a Reliable Model for Normal Human Mammary Epithelial Cells.

Qu Y, Han B, Yu Y, Yao W, Bose S, Karlan BY, Giuliano AE, Cui X.

PLoS One. 2015 Jul 6;10(7):e0131285. doi: 10.1371/journal.pone.0131285. eCollection 2015.

46.

Is mastectomy undertreatment for low-risk breast cancers eligible for breast-conserving therapy?

Bagaria SP, Wasif N, Rawal B, McLaughlin SA, Giuliano AE.

Cancer. 2015 Aug 15;121(16):2705-12. doi: 10.1002/cncr.29416. Epub 2015 Apr 28.

47.

Critical protein GAPDH and its regulatory mechanisms in cancer cells.

Zhang JY, Zhang F, Hong CQ, Giuliano AE, Cui XJ, Zhou GJ, Zhang GJ, Cui YK.

Cancer Biol Med. 2015 Mar;12(1):10-22. doi: 10.7497/j.issn.2095-3941.2014.0019. Review.

48.

Sentinel node biopsy and improved patient care.

Giuliano AE, Gangi A.

Breast J. 2015 Jan-Feb;21(1):27-31. doi: 10.1111/tbj.12365. Epub 2014 Dec 26.

PMID:
25546431
49.

Evaluation of the stage IB designation of the American Joint Committee on Cancer staging system in breast cancer.

Mittendorf EA, Ballman KV, McCall LM, Yi M, Sahin AA, Bedrosian I, Hansen N, Gabram S, Hurd T, Giuliano AE, Hunt KK.

J Clin Oncol. 2015 Apr 1;33(10):1119-27. doi: 10.1200/JCO.2014.57.2958. Epub 2014 Dec 8.

50.

Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research.

Moossdorff M, van Roozendaal LM, Strobbe LJ, Aebi S, Cameron DA, Dixon JM, Giuliano AE, Haffty BG, Hickey BE, Hudis CA, Klimberg VS, Koczwara B, Kühn T, Lippman ME, Lucci A, Piccart M, Smith BD, Tjan-Heijnen VC, van de Velde CJ, Van Zee KJ, Vermorken JB, Viale G, Voogd AC, Wapnir IL, White JR, Smidt ML.

J Natl Cancer Inst. 2014 Nov 7;106(12). pii: dju288. doi: 10.1093/jnci/dju288. Print 2014 Dec.

Supplemental Content

Loading ...
Support Center